Citation Impact
Citing Papers
Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study
2008 Standout
OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
2012 Standout
Pegylated Liposomal Doxorubicin and Carboplatin Compared With Paclitaxel and Carboplatin for Patients With Platinum-Sensitive Ovarian Cancer in Late Relapse
2010
Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
2009
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
2010 StandoutScience
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
2003 Standout
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Weekly cisplatin and daily oral etoposide is highly effective in platinum pretreated ovarian cancer
2002
Intraperitoneal chemotherapy: Analysis of complications with an implanted subcutaneous port and catheter system
1991
Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis
2002 Standout
Nasopharyngeal carcinoma
2005 Standout
Ultraradical debulking of epithelial ovarian cancer with the ultrasonic surgical aspirator: A prospective randomized trial
1996
Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
2015 Standout
A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: A population-based study of 4317 women diagnosed in Denmark 1978–2006
2012
Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer
2005
Ifosfamide plus Cisplatin as Primary Chemotherapy of Advanced Ovarian Cancer
1997
Centralised treatment, entry to trials and survival
1994
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
2009
A view on drug resistance in cancer
2019 StandoutNature
Resectable adenocarcinoma of the rectosigmoid and rectum. I. Patterns of failure and survival
1988
No Downstaging After Short-Term Preoperative Radiotherapy in Rectal Cancer Patients
2001
Radiotherapy in addition to radical surgery in rectal cancer: Evidence for a dose-response effect favoring preoperative treatment
1997
Effect of p53 Gene Transfer and Cisplatin in a Peritonitis Carcinomatosa Model with p53-Deficient Ovarian Cancer Cells
2002
Endometriosis-Associated Ovarian Carcinoma (EAOC): An Entity Distinct from Other Ovarian Carcinomas as Suggested by a Nested Case-Control Study
2001
Adjuvant radiotherapy for stage I endometrial cancer: systematic review and meta-analysis
2007
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
2003 Standout
First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence
2002
Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial
2003 Standout
Ovarian cancer
2014 Standout
Radiotherapy in Addition to Radical Surgery in Rectal Cancer
1995
Anti-tumor effect of intraperitoneal administration of cisplatin-loaded microspheres to human tumor xenografted nude mice
2002 StandoutNobel
Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year Results
2000
Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) study
2005
Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer
2001
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial
2002 Standout
A comparison of nonoperative vs. preoperative radiotherapy in rectal carcinoma
1989
The role of cytoreductive surgery in the management of stage IV epithelial ovarian carcinoma
1992
Soft-Tissue Sarcomas in Adults
2005 Standout
Transfusion Medicine — Blood Transfusion
1999 Standout
Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program.
1993
The Role of Adjuvant Radiotherapy in Carcinoma of the Endometrium—Results in 550 Patients with Pathologic Stage I Disease
1998
Current Management Strategies for Ovarian Cancer
2007
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
2004 Standout
Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial
2013
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
2011 Standout
A phase II trial of ZD0473 in platinum-pretreated ovarian cancer
2002
A Critique of Surgical Cytoreduction in Advanced Ovarian Cancer
2000
Incidence and patterns of recurrence following curative resection for colorectal carcinoma
1997
Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands
1998
Preoperative Radiotherapy as Adjuvant Treatment in Rectal Cancer
1988
Blood Transfusions and Prognosis in Colorectal Cancer
1993
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
2004 Standout
Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: Follow-up of a Southwest Oncology Group and Gynecologic Oncology Group phase 3 trial
2009
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma
2004
Cellular processing of platinum anticancer drugs
2005 Standout
Comparison of Baseline Characteristics, Management and Outcome of Patients With Non–ST-Segment Elevation Acute Coronary Syndrome in Versus Not in Clinical Trials
2010
The value of adjuvant radio(chemo)therapy for rectal cancer
1995
Presurgical diagnosis of adnexal tumours using mathematical models and scoring systems: a systematic review and meta-analysis
2013
Circulating mutant DNA to assess tumor dynamics
2008 Standout
Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial
2000 Standout
Effective Surgical Adjuvant Therapy for High-Risk Rectal Carcinoma
1991
Cytoreductive surgery for advanced stages of ovarian cancer
2000
Regulated necrosis: disease relevance and therapeutic opportunities
2016
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
2001 Standout
Combined Carboplatin plus Ifosfamide and Cisplatin in Patients with Advanced Ovarian Carcinoma. A Phase I–II Study
1998
Variations in institutional infrastructure, physician specialization and experience, and outcome in ovarian cancer: A systematic review
2008
Treatment of stage I nasopharyngeal carcinoma: Analysis of the patterns of relapse and the results of withholding elective neck irradiation
1989
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphaide therapy in advanced ovarian adenocarcinoma
1994
Preoperative radiotherapy in rectal carcinoma—Aspects of acute adverse effects and radiation technique
1996
True
2000
Pre- or Postoperative Radiotherapy in Rectal and Rectosigmoid Carcinoma Report from a Randomized Multicenter Trial
1990
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
2006 Standout
Preoperative or postoperative irradiation in adenocarcinoma of the rectum
1993
Intraperitoneal cisplatin‐based chemotherapy vs. intravenous cisplatin‐based chemotherapy for stage III optimally cytoreduced epithelial ovarian cancer
2001
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Erythropoietin increases hemoglobin in cancer patients during radiation therapy
1993
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
2010 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Recent Advances in Radiation Oncology
1995
Preoperative radiotherapy in operable rectal cancer
1990
Surgical Staging and Treatment of Early Ovarian Cancer: Long-term Analysis From a Randomized Trial
2010
Carboplatin versus cisplatin in solid tumors: An analysis of the literature
1998
High-Dose Platinum versus Standard Dose in Advanced Ovarian Carcinoma: A Randomized Trial from the Gynecologic Cooperative Group of the French Comprehensive Cancer Centers (FNCLCC)
2000
Cancer of the Ovary
2004 Standout
Perineural invasion in cancer
2009 Standout
Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate
2002
Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
2007
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock.
1968
Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer
1998
INCIDENCE AND SEVERITY OF ANAPHYLACTOID REACTIONS TO COLLOID VOLUME SUBSTITUTES
1977 Standout
The Relationship of Molecular Markers of p53 Function and Angiogenesis to Prognosis of Stage I Epithelial Ovarian Cancer
2005
Phase III Randomized Trial of 12 Versus 3 Months of Maintenance Paclitaxel in Patients With Advanced Ovarian Cancer After Complete Response to Platinum and Paclitaxel-Based Chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group Trial
2003
Second-Line Treatment of Ovarian Cancer
2000
Current Management Strategies for Ovarian Cancer
2007
Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography—A prospective study
2007
Review: Practical considerations in ovarian cancer chemotherapy
2010
Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized Study
2004
Intraepithelial CD8+tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
2005 Standout
Impact of Adjuvant Chemotherapy and Surgical Staging in Early-Stage Ovarian Carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm Trial
2003
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
2003 Standout
Adjuvant Treatment for Early Ovarian Cancer: A Randomized Phase III Trial of Intraperitoneal 32P or Intravenous Cyclophosphamide and Cisplatin—A Gynecologic Oncology Group Study
2003
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial
2003 Standout
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer
2011
Staging classification for cancer of the ovary, fallopian tube, and peritoneum
2013
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
1997 Standout
Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
2009 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma
1993
Intraperitoneal treatment and dose-intense therapy in ovarian cancer
1999
Perineural Invasion Is an Independent Predictor of Outcome in Colorectal Cancer
2009
Phase III Trial of Observation Versus Six Courses of Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer in Complete Response After Six Courses of Paclitaxel/Platinum-Based Chemotherapy: Final Results of the After-6 Protocol 1
2009
Works of K. Bertelsen being referenced
[DEATH DUE TO PENICILLIN. 16 DANISH CASES WITH AUTOPSIES].
1965
A Prospective Randomized Comparison of 6 and 12 Cycles of Cyclophosphamide, Adriamycin, and Cisplatin in Advanced Epithelial Ovarian Cancer: A Danish Ovarian Study Group Trial (DACOVA)
1993
A regression analysis of prognostic factors after resection of Dukes' B and C carcinoma of the rectum and rectosigmoid. Does post-operative radiotherapy change the prognosis?
1988
Protocol allocation and exclusion in two Danish randomised trials in ovarian cancer
1991
Altretamine (hexamethylmelamine) in the treatment of platinum-resistant ovarian cancer: a phase II study
2003
Intraperitoneal carboplatin in the treatment of minimal residual ovarian cancer
1990
A multicenter phase II study of carboplatin in advanced ovarian carcinoma: Final report
1992
High-dose platinum chemotherapy in advanced ovarian cancer: A phase II study
1992
Intraperitoneal chemotherapy: Introduction of a new “single use” delivery system—A preliminary report
1989
Blood transfusion and prognosis in Dukes' B and C colorectal cancer
1990
Tumor reduction surgery and long-term survival in advanced ovarian cancer: A DACOVA study
1990
Long-term survival and prognostic factors in advanced epithelial ovarian cancer with special emphasis upon the effects of protocol inclusion
1994
Prognostic factors and adjuvant treatment in early epithelial ovarian cancer
1993
Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study.
1997
Phase II Study of Vinorelbine in the Treatment of Platinum-Resistant Ovarian Carcinoma
2001
A Phase 2 Trial of Ifosfamide/Mesna as Salvage Therapy in Patients with Ovarian Cancer Refractory to or Relapsing after Prior Platinum-Containing Chemotherapy
1995
Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis
1992
Misonidazole combined with radiotherapy in the treatment of carcinoma of the uterine cervix
1989
Use of tumour markers in monitoring the course of ovarian cancer.
1999
Reproducibility and prognostic value of histologic type and grade in early epithelial ovarian cancer
1993
Cyclic hormonal treatment in ovarian cancer. A phase-II trial
1987
How long should first-line chemotherapy continue?
1999
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma
2001
Long-term follow-up of patients with advanced ovarian carcinoma treated with chemotherapy
1993
Use of tumour markers in monitoring the course of ovarian cancer
1999
Postoperative radiotherapy in rectosigmoid cancer Dukes' B and C
1982
[Patients with early stages of endometrial cancer should be spared adjuvant radiotherapy. Danish Endometrial Cancer Group].
1997
Intergroup collaboration in ovarian cancer: a giant step forward
1999
Malignant Tumours of the Nasopharynx
1975
Is cisplatin-taxol (PT) the standard treatment in advanced ovarian cancer. The NOCOVA
1997
Comparison of CA-125 and Standard Definitions of Progression of Ovarian Cancer in the Intergroup Trial of Cisplatin and Paclitaxel Versus Cisplatin and Cyclophosphamide
2005
Adjuvant radiation therapy is not necessary in the management of endometrial carcinoma stage I, low-risk cases
1996
Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid: A randomized multicenter study
1986